Integration of HIV-1 linear DNA into the host chromatin is an essential step in the viral life cycle. However, the majority of reverse-transcribed, nuclear-imported viral genomes remain episomal, either as linear or circular DNA. To date, these nonintegrated viral genomes are largely considered ''dead-end products'' of reverse transcription. Indeed, limited gene expression from nonintegrated HIV-1 has been reported, although the mechanism that renders nonintegrating HIV-1 genomes incapable of supporting efficient viral replication has not been fully elucidated. Here, we demonstrate that nonintegrating HIV-1 and HIV-1-based vector genomes are organized into chromatin structures and enriched with histone modifications typical of transcriptionally silenced chromatin. Gene expression and replication of nonintegrating HIV-1 was notably increased in vitro upon exposure to histone deacetylase inhibitors (HDACi) in the form of various short-chain fatty acids (SCFAs) known to be endogenously produced by normal microbial-gut flora. Furthermore, we demonstrated genetic and functional crosstalk between episomal and integrated vector/viral genomes, resulting in recombination between integrated and nonintegrated HIV-1, as well as mobilization of episomal vector genomes by productive viral particles encoded by integrated viral genomes. Finally, we propose a mechanism describing the role of episomal HIV-1 forms in the viral life cycle in a SCFA-rich gut environment.
episomal expression ͉ HDAC inhibitors ͉ histone modifications I n contradiction to the central role of integration in the HIV-1 life cycle, the majority of viral genomes remain episomal after nuclear import, either as linear or circular DNA (1) . The passive, yet rapid, loss of episomal HIV-1 forms in dividing cells, such as activated T cells, is only part of a complex mechanism rendering nonintegrating HIV-1 forms replication-defective. This view is premised on a number of in vitro studies demonstrating the stability of circular HIV-1 episomes in T cell lines and the persistence of integrasedeficient HIV-1 in nondividing primary macrophages (2, 3) . Supporting this notion are early reports describing the accumulation of episomal HIV-1 forms in the brain tissue of AIDS patients and more recent studies demonstrating the persistence of nonintegrating HIV-1 vector forms in various rodent tissues in vivo (4) . Surprisingly, a study by Cara et al. described the replication of integrase-deficient HIV-1 in primary macrophages (5) . However, this report is in contrast to a large body of studies from several research groups that demonstrated fundamental differences in the level and regulation of gene expression from episomal and integrated HIV-1 genomes (3, 6) . These studies imply that altered viral gene expression from HIV-1 forms may be involved in the mechanism that renders nonintegrating HIV-1 replication-defective. In fact, the use of integrase-deficient, HIV-1-containing reporter genes in place of early or late proteins (nef, gag) demonstrated that episomal HIV-1 lacks the capability to express proteins encoded by either unspliced or fully spliced viral mRNAs in CD4-positive cells (7, 8) . Conversely, expression of env-, tat-, and nef-encoding mRNAs from nonintegrating HIV-1 was observed, although only the fully spliced mRNAs were translated to nef and tat proteins (9).
Furthermore, episomal expression has been reported in a cell line-dependent manner (2, 6) . Importantly, the level of episomal nef expression was sufficient to downregulate CD4 expression on host cell surfaces and to induce T cell activation (2) . These findings suggest that gene expression from nonintegrating HIV-1 forms can potentially affect the life cycle and pathogenesis of HIV-1. This notion was corroborated by a recent report showing the ability of integrated HIV-1 provirus to support packaging of episomally transcribed viral genomes into infectious particles (7) .
A recent report by Bayer et al. showed a significant reduction in transgene expression from an internal CMV promoter in nonintegrating self-inactivating (SIN) HIV-1 vectors in comparison with their integrated counterparts (10) . Furthermore, a minimal deletion in the vector's U3 region dramatically reduced transcription from an internal CMV promoter in episomal vectors, yet had no effect on transgene expression from identical integrated vectors. These findings raise the possibility that the observed differences in proviral and episomal HIV-1 gene expression are analogous to the differences observed in gene expression following stable and transient transfection of gene-expression cassettes containing retroviral LTRs (11) . Importantly, several reports have shown that the genomes of DNA viruses, including SV40, EBV, HSV, AAV, and HBV, are organized into chromatin-like structures, which have major effects on viral gene expression and life cycle (12) (13) (14) (15) . Interestingly, a recent study demonstrated that the transcriptional characteristics of episomal HIV-1 forms generated in the course of transduction significantly differ from those of transiently transfected DNA (16) . Ma et al., in showing the ability of SIN and non-SIN single-LTR plasmids to support the production of hightiter vector particles following transient transfection, corroborated this notion (17) . Notwithstanding these reports, the possibility that the replication deficiency of the episomal majority of HIV-1 genomes may be partly due to a repressive chromatin structure has not been tested.
In this study, we demonstrate that episomal HIV-1 and HIV-1 vectors are associated with histones and organized into chromatin structures typical of silent chromatin. Furthermore, gene expression from the viral episomes was increased significantly upon exposure to histone deacetylase inhibitors (HDACi) in the form of shortchain fatty acids (SCFAs), some of which are known bacterial metabolites generated in large quantities by the normal gut flora. In addition, we demonstrated crosstalk between episomes and integrase-proficient HIV-1, resulting in mobilization of episomal vectors and genetic complementation of envelope-deficient HIV-1. Premised on these findings, we suggest that episomal HIV-1 genomes have a significant role in the viral life cycle, especially in such early stages as establishing productive infection in the gut.
Results
Promoter-Independent Silencing of Episomal HIV-1 Vectors. A recent study demonstrating downregulation of transcription from nonintegrating HIV-1 vectors carrying an internal CMV promoter implied that transcriptional silencing might be inherent to episomal HIV-1 vector forms (10) . To rule out the possibility that the observed low level of episomal transgene expression stemmed from CMV promoter susceptibility to silencing, we used FACScan analysis to compare GFP expression from episomal and integrating vectors containing silencing-resistant promoters: CAG, EF1a, and PGK1 (18, 19) . As shown in Fig. S1 , regardless of the promoter used, GFP expression from integrating HIV-1 vectors was at least 4-fold higher than that of their episomal counterparts. These findings raised the possibility that gene expression from episomal HIV-1 vectors is regulated on higher levels than the vectors' internal promoter.
HDACi Activate Episomal HIV-1 Vector Genomes Associated with
Histone Modifications Typical of Silenced Chromatin. The general nature of episomal HIV-1 vector silencing, and the fact that transcriptional regulation of nonintegrating DNA viruses involves modifications in chromatin structures organizing these episomal viral genomes (12) , raised the possibility that transcriptionallydownregulated episomal HIV-1 vectors are also organized into nucleosomal structures. To test this hypothesis, a chromatin immunoprecipitation (ChIP) assay was used to determine whether histone H3, one of the major four histones comprising the nucleosomal core, is associated with episomal HIV-1 vector genomes. As shown in Fig. S2 A, the association of histone H3 with episomal and integrating HIV-1 vector genomes was comparable. Although intriguing, the mere association of histone H3 with episomal vector genomes could not support the notion that episomal HIV-1 genomes are organized into chromatin structures. However, direct evidence for this hypothesis was provided by a micrococcal nuclease (MNase) assay used on episomal and integrated vector genomes following transduction of 293T cells with either integrase-proficient or -deficient HIV-1 vector particles. We show here the nucleosomal-ladder array typical of chromatin structures for both integrated and episomal vectors (Fig. S3A ). As expected, unlike the integrated vectors, the diluted episomal vector genomes could not be detected after three passages in culture. The findings that episomal genomes are organized into chromatin raised the possibility that specific chromatin modifications render the episomal HIV-1 vector forms less accessible to host transcriptional machinery. This idea was supported by a DNaseI sensitivity assay demonstrating that episomal HIV-1 genomes were significantly more resistant to DNaseI degradation than similar, but integrated, vector genomes (Fig. S3B) . Quantitative-scan analysis of the resulting autoradiogram confirms that observation (Fig. S3B ). Histone modifications, such as acetylation of H3 and H4 and di-and trimethylation of H3 lysine 4 (H3-K4), have been associated with open chromatin and gene activation, while closed chromatin and gene repression have been associated with trimethylation of H3 lysine 9 (H3-K9) (20) . To study further the mechanism of episomal vector silencing, a ChIP assay was used to determine which of the above histone modifications were associated with integrated and episomal HIV-1 vectors at day 3 pt and following 14 days in culture (without being passaged) in human embryonic fibroblasts (HEFs). The vectors expressed firefly luciferase under the control of the CMV promoter to correlate between the vectors' histone modifications and transgene expression. As shown in Fig. 1A and Fig. S2 A, the histone modification profile associated with the CMV promoter in the episomal HIV-1 vector genomes is typical of transcriptionally repressed genes, showing low levels of H3 and H4 acetylation, H3-K4 dimethylation, and enrichment of trimethylated H3-K9, comparable to the level found associated with the endogenous (inactive) ␤-globin promoter. In contrast to episomal vectors and similar to the promoter of the housekeeping gene GAPDH, the CMV promoter in the integrated HIV-1 vector exhibited a high level of association with acetylated H3 and H4, dimethylated H3-K4, and minimal association with trimethylated H4-K9 (Fig. 1 A) . To correlate the profile of chromatin structure, histone modification, and transcriptional activity of the integrated and episomal vectors, luciferase activity was measured at days 3 and 14 pt (Fig. 1C ). In accordance with the differences in DNaseI sensitivity and histone modification profiles, transgene expression from the integrated vector forms was 30-and 40-fold higher than the level of expression obtained from their episomal counterparts at days 3 and 14, respectively (Fig. 1C) . Importantly, exposure of episomal vector-transduced cells to HDACi, sodium butyrate (SB) resulted in a roughly 7-fold increase in episomal transgene expression at day 3 pt (Fig. 1C) , with concomitant increases in H3 and H4 acetylation and H3-K4 dimethylation (Fig. 1 A) . However, the exposure to SB did not lead to significant reduction in the level of H3-K9 trimethylation ( Fig. 1 A  and Fig. S2 A) . Interestingly, similar HDACi-induced changes in histone modifications associated with episomal vectors were observed at day 14 pt (Fig. 1B and Fig. S2B ), although without a corresponding increase in episomal transgene expression (Fig. 1C) . These findings indicated that additional layers of regulation, including DNA methylation or different histone modifications, rendered the episomal vector silencing resistant to HDACi in a time-dependent manner. However, DNA methylation analysis of the CMV promoter by either methylation-sensitive restriction enzymes or the bisulfite assay failed to detect methylated CpG sequences ( Fig. S3 C and D) .
Episomal HIV-1 Genomes Generated by a Single Round of Infection Are Associated with Transcriptionally Repressive Histone Modifications
and Are Activated by HDACi. To determine whether histone modifications typical of silenced chromatin are involved in the transcriptional downregulation of integrated and episomal HIV-1 genomes, SupT1 cells were subjected to a single round of infection with integrating or integrase-deficient (vD64E) VSV-G-pseudotyped viruses. Cloning of the firefly luciferase gene in place of the nef-coding sequence in both viruses allowed direct evaluation of viral gene expression. As shown in Fig. 2A , although luciferase gene expression and viral particle release (as measured by p24 gag ELISA) from nonintegrating HIV-1 were significantly lower than the levels obtained from integrating HIV-1, expression and particle release from both viruses are increased dramatically upon exposure to 5 mM SB or valproic acid, an HDACi ( Fig. 2C and Fig. S4A ). Similar to the CMV promoter of episomal HIV vector genomes, nonintegrating HIV LTRs were found to be associated with the unmodified histone H3 and exhibit a profile typical of silent chromatin, including low levels of H3 and H4 acetylation and H3-K4 dimethylation, and high levels of H3-K9 trimethylation (Fig. 2B and Fig. S5 ). As expected, the increase in luciferase expression and particle release from both viruses observed upon exposure to 5 mM SB was accompanied by a significant increase in histone acetylation and H3-K4 dimethylation (Fig. 2B and Fig. S5 ). Interestingly, and in accordance with results derived from HIV vectors, the observed high levels of trimethylated-H3-K9 histones were not accompanied by CpG DNA methylation (Fig. S3E) .
Endogenous HDACi in the Form of SCFAs Generated by Normal Gut
Bacteria Activate Transcriptionally Silenced HIV-1 Episomes. The significant effects of butyric and valproic acids on episomal HIV-1 gene expression and particle release in vitro raised the possibility that other HDAC-inhibiting SCFAs naturally generated in vivo could potentially produce the same effect. Endogenously produced SCFAs are formed in the process of carbohydrate and protein catabolism by the normal bacterial flora of the gut, as well as by different bacterial strains in the oral cavity (21, 22) . Acetic, propionic, and butyric acids are the predominant SCFAs in the gut, while other bacteria-derived SCFAs, including formic, valeric, hexanoic, and heptanoic acids, as well as branched compounds such as isovaleric, isobutyric, and 2-methylbutyric acids, are formed in significantly lesser amounts (21) . To test the ability of bacteriaderived SCFAs to upregulate episomal HIV-1 vector gene expression, integrase-deficient vector particles encoding either GFP or luciferase were used on 293T cells either in the presence or absence of various SCFAs (Fig. S4 B and C) . Excluding acetic acid and the branched compound 2-methylbutyric acid, all of the tested bacteriaderived SCFAs significantly increased episomal-vector gene expression. Interestingly, SCFAs have demonstrated similar effects on expression from integrase-proficient HIV-1 (Fig. S4C) . Importantly, analogous effects of SCFAs on episomal HIV-1 expression and viral particle release were obtained following a single round of infection in SupT1 cells transduced with the VSV-G-pseudotyped, integrase-deficient virus vD64E (Fig. 2C) . Interestingly, spent media collected from the SCFA-producing bacteria PG4, a Porphyromonas gingivalis strain, and FN, a Fusobacterium nucleatum strain isolated from the human oral cavity and gut, respectively, also increased episomal gene expression and particle release (Fig. 2C) . In contrast, spent media collected from Gram-positive Streptococcus mutans, a pathogenic oral bacterium lacking the ability to produce SCFAs, failed to elicit similar increases in episomal HIV-1 gene expression and particle release (Fig. 2C) .
Efficient Replication of Episomal HIV-1 in Primary Monocyte-Derived
Macrophages (MDMs) Exposed to SCFAs. Intrigued by the singleround-of-infection assays demonstrating the ability of SCFAs to increase episomal gene expression and enhance viral particle release from SupT1 cells transduced with integrase-deficient HIV-1, we investigated whether HDACi, including valproic acid and various SCFAs formed naturally by gut bacteria, could also support episomal HIV-1 replication in natural HIV-1 host cells. To this end, MDMs were infected with either integrating or integrasedeficient dual-tropic HIV-1 (89.6) in the presence and absence of HDACi. Viral replication was measured by p24
gag ELISA for accumulation of viral particles in conditioned media. As shown in (23) . Indeed, recent reports provided encouraging indications regarding the therapeutic potential of the INi raltegravir (MK5018) for AIDS patients (24) . Intrigued by these studies, we characterized the effects of SCFAs on HIV-1 replication in MDMs in the presence of raltegravir. The data presented in Fig.  3B demonstrate that the inhibitory effects of raltegravir on HIV-1 replication (10-fold reduction in p24 gag ) were partially alleviated by a number of SCFAs. Interestingly, exposure to HDACi resulted in an increase in viral particle release following infection of SupT1 cells with wild-type and integrase-deficient HIV-1 particles (Fig.  S6A) . However, in contrast to MDMs, episomal particle release was not sustained in the rapidly dividing SupT1 cells as suggested earlier (25) . Furthermore, these data are in line with an earlier study by Cara et al. in which nonintegrating HIV-1 was serially passaged in MDMs (5) . Intrigued by these data, we wished to characterize the specific activity of HIV-1 particles derived from episomal viral genomes. To this end, HIV-1 particles were generated in SupT1 either in the presence or absence of raltegravir and used on naive SupT1 cells (Fig. S6B) . HIV-1 replication in the presence and absence of HDACi was determined by measuring p24. As shown in Fig. S6C , HIV-1 particles generated in the presence of raltegravir were able to replicate in naive SupT1 cells. However their initial rate of replication was (first 11 days) slower than the replication of HIV-1 particles generated in the absence of raltegravir (Fig. S6C) . Interestingly, viral replication was accelerated in the presence of HDACi (Fig. S6C) . These data suggested that although infectious HIV-1 particles generated from episomal genomes are less infectious than particles generated from integrated provirus templates, they are capable of initiating the viral life cycle. This notion was supported by qPCR analysis demonstrating the presence of 1 and 0.075 viral genomes per 100 SupT1 cells infected at m.o.i. of 0.2 with viral particles generated by wild-type and integrase-deficient HIV-1, respectively, altogether these findings suggest that episomal HIV-1 genomes can serve as a template to integration-competent progenies capable of completing the HIV-1 life cycle.
Productive Crosstalk Between Episomal HIV-1, Nonintegrating HIV-1
Vectors, and Integrase-Proficient HIV-1. Our findings could not rule out the possibility that various HIV-1 gene products can complement the deficiencies of episomal viral gene expression. Indeed, support to this notion was provided by an earlier study demonstrating the ability of the HIV-1 vpr to activate episomal gene expression (16) . These data suggest that episomal HIV-1 replication could be supported upon co-infection of a target cell with integrating viruses. To test this hypothesis, MT4 cells were subjected to consecutive infections with integrase-deficient HIV-1 carrying the luciferase gene in the viral nef coding sequences, followed 16 h later by infection with the wild-type viral strain NL4-3. Naive MT4 target cells contained in cell chambers were co-cultivated for 4 days with the doubly infected MT4 cells. Mobilization of viral genomes carrying the luciferase gene into the naive MT4 target cells was determined by real-time PCR. As shown in Fig. S7A , viral genomes derived from integrase-deficient viruses containing the luciferase gene were efficiently mobilized into the naive MT4 cells. However, sequence analysis of the integrase gene in all mobilized, luciferase-containing viral genomes demonstrated the wild-type integrase sequence. These finding were in line with an earlier study by Gelderblom et al. demonstrating recombination between reverse-transcribed wild-type and integrase-deficient viral genomes (7) . Interestingly, complementation of viral envelope protein by episomal viral genomes was observed following coinfection of MT4 cells with VSV-G-pseudotyped, integrating HIV-1 lacking functional envelope with integrase-deficient virus encoding functional HIV-1 envelope (Fig. S7A) . Next, we sought to employ a vector mobilization assay as a means to evaluate further the replication potential of episomal HIV-1.
To this end, MT4 cells transduced with either integrating or integrase-deficient HIV-1 vector vTK469 were superinfected with either wild-type or integrase-deficient (D64E) HIV-1 (Fig. S7B) . As expected, mobilization of integrated vector by wild-type NL4-3 virus was highly efficient, resulting in the detection of one vector genome per 10 target MT4 cell genomes (Fig. S7B) . Importantly, episomal viral genomes supported mobilization of integrated vectors, while episomal vector genomes were efficiently mobilized by integrating HIV-1, allowing the detection of 15 and 11 mobilized genomes per 1,000 target cell genomes (Fig. S7B) . These data are in line with an earlier study supporting the notion that productive crosstalk and complementation could exist between integrating and episomal HIV-1 genomes (7).
Discussion
In agreement with earlier reports, the data presented here indicate that gene expression from nonintegrated HIV-1 and HIV vectors is significantly lower than that of their integrated counterparts (6, 16) and that episomal HIV vector silencing is promoterindependent. Furthermore, we showed that episomal HIV-1 and HIV-1 vector genomes are organized into nucleosomal structures, enriched in histone modifications typical of silenced chromatin, and thus subjected to layers of gene regulation involved in transcriptional silencing of cellular gene expression. The central role of viral-genome chromatinization on gene expression and the life cycle of nonintegrating DNA viruses, including SV40, EBV, HSV, AAV, HBV, and others, has been well documented (11) (12) (13) . In particular, a number of research groups focusing on the early stages of the herpes viral life cycle have described a competition between cellular epigenetic silencing of viral genes and viral inhibition of HDAC activity mediated by ICP0 and U s 3, as well as IE1 and IE2 of HSV1 and CMV, respectively, to enable the expression of viral genes (26, 27) . In analogy to this phenomenon, we showed that HDACi significantly increased gene expression from episomal vector and viral forms following transduction of various cell lines, as well as primary MDMs, with integrase-deficient HIV-1-based vectors and HIV-1. Furthermore, upon exposure to HDACi, a substantial increase in HIV-1 particle release was observed from MDMs following multiple rounds of HIV-1 infection in the presence of the clinically used INi raltegravir. Importantly, the increase in episomal HIV-1 gene expression was accompanied by a concomitant increase in episomal viral and vector genomes associated with histone modifications typical of active chromatin. Notwithstanding the increase in episomal expression, the exposure to HDACi did not result in a significant decrease in the association of episomal genomes with trimethylated H3-K9 typical of silent chromatin. Thus, the role of this modification in marking episomal HIV-1 genomes for transcriptional silencing should be further investigated, especially since trimethylated H3-K9 was shown to be directly involved in DNA methylation (28) . In this regard, CpG sequences in episomal HIV-1 vectors were found not methylated; however, the notion that additional chromatin modifications and layers of regulation are involved in episomal HIV-1 silencing was supported by the fact that at day 14 pt the HDAC inhibitors mediated an increase in H3 and H4 histone acetylation associated with episomal vectors that was not accompanied by an increase in episomal transgene expression. These results are in accord with earlier data demonstrating efficient silencing of HIV-1 vectors independent of DNA methylation (29) .
Although it is possible that the silencing of HIV-1 includes all forms of reverse-transcribed HIV-1 genomes (including the linear form required for integration), it appears that, through integration into active-chromatin regions associated with histone modifications typical of active chromatin, the silencing of proviral HIV-1 genomes is partly alleviated (30, 31) . Indeed, particle release and gene expression from integrated HIV-1 and HIV-1 vectors, which were always significantly higher than the levels obtained from their nonintegrating counterparts, were further increased upon exposure of viral/vector transduced cells to HDACi.
The replication timing of proviral HIV-1 genomes has not been characterized. However, the favored HIV-1 integration sites in active transcription units suggest that integrated HIV-1 and HIV-1 vector genomes replicate in early S-phase, which may further enhance proviral gene expression (32) .
Two sources of HDACi can be considered potential means by which epigenetic silencing of HIV-1 gene expression might be alleviated: (i) HDACi encoded by other viruses co-infecting similar HIV-1 targets and (ii) HDAC inhibitors in the form of SCFAs generated by the gut's normal bacterial flora. In line with the second possibility, a recent study demonstrated that bacteriaderived SCFAs upregulated KSHV replication (22) . Here we provide evidence that SCFAs, similar to those generated in the gut (21) , significantly increase transgene expression from episomal HIV-1 vectors, as well as gene expression, particle release, and replication of integrase-deficient and wild-type HIV-1 from MDMs and SupT1 cells in the presence of raltegravir, the INi currently in clinical trials for HIV-1 treatment (23). These findings are in line with a recent publication demonstrating activation of latent HIV-1 provirus by bacteria-derived SCFAs (33) . Thus, these data provide a direct indication that SCFAs-mediated activation of episomal and integrated HIV-1 plays a major role in the early phase of HIV-1 infection, during which CD4 ϩ cells in the gut-associated lymphatic tissue (GALT) are first to be lost and are the last to be recovered upon HAART (34) . Interestingly enough, nonintegrated HIV-1 genomes have been found to be the most prevalent form of HIV-1 DNA in resting CD4 ϩ T cells and macrophages undergoing HAART treatment (1) . Thus, the finding reported here suggests that nonintegrating HIV-1 forms may serve as an additional reservoir in AIDS patients.
Aware of the fact that significant numbers of HIV-1-infected cells contain more than one viral genome (35), we demonstrate a viable crosstalk between integrated and episomal HIV-1 forms, which, similar to an earlier report, allowed recombination between integrase-deficient and wild-type viral genomes (7) . Overall, this study demonstrates that chromatinized episomal HIV-1 genomes are subject to epigenetic silencing, which can be alleviated by HDACi, including SCFAs generated by the normal bacterial flora of the gut and thus, strongly indicates that episomal HIV-1 forms and SCFAs could play an important role in the early phases of HIV-1 infection, especially when the initial viral load is low. Importantly, the lymphotoxic properties of SCFAs observed by several laboratories (36) may contribute to the rapid decline in CD4 ϩ cell counts in the gut during early-phase HIV infection. Furthermore, the effects of bacteria-derived SCFAs on viral replication are probably extended outside the GALT, upon damage to the gut mucosa and leakage of bacterial products into the circulatory system.
Methods
Plasmids and Virus Production. Vectors and viruses were generated through transient transfection of 293T cells (37) . pTK113 and pTK469, respectively, and ⌬NRF, ⌬NRF-E152A, and pTK939 (⌬NRF-D64E) packaging plasmids have been described previously (10, 17) . All other plasmids used in this study are described in the SI Methods.
Cells and Infection. 293T, HEFs, MT4, vTK469-expressing MT4, Jurkat, Jurkat-⌬KS, SupT1, and MDM cells were used in this study. MDMs were also supplemented with GM-CSF, as described in (SI Methods). For multiple-round infections, cells were infected at a concentration of 25-50 ng p24/million target cells, and virus was harvested every 4 days, while for single-round infections, cells were infected at an m.o.i. of 0.2 and harvested after 3 days. For transductions, cells received vector at an m.o.i. of 0.2-2.5 and were harvested after 3 and 14 days. p24 gag ELISA. Vector and virus particle number were measured using the National Institutes of Health p24 Antigen Capture Assay kit. Results are presented in physical particles (PP)/mg protein/copy number/cell (described below), or in ng p24/mL. PP was calculated as 1 ng; p24 is equal to 4,000 PP.
Luciferase Assay. Luciferase expression was measured using a Victor 3 multilabel counter (PerkinElmer). Results are represented as relative light units (RLU)/mg protein/copy number/cell.
Chromatin Immunoprecipitation. The ChIP assay was performed as described (38) (see also SI Methods).
Real-Time PCR. DNA for real-time PCR was prepared as described (10) .
